TOVX icon

Theriva Biologics
TOVX

Overview Fund Trends Analyst Outlook Journalist POV

74 hedge funds and large institutions have $27.4M invested in Theriva Biologics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 13 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less ownership

Funds ownership: →

less capital invested

Capital invested by funds: $ → $

24% less repeat investments, than reductions

Existing positions increased: 13 | Existing positions reduced: 17

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
74
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.59M
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$3.52M
2
+$1.66M
3
+$70.6K
4
PPA
Parametric Portfolio Associates
Washington
+$52K
5
Northern Trust
Northern Trust
Illinois
+$44.3K

Top Sellers

1
-$1.55M
2
-$1.02M
3
-$356K
4
Alyeska Investment Group
Alyeska Investment Group
Illinois
-$271K
5
Millennium Management
Millennium Management
New York
-$242K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$76K
27
$75K
28
$68K
29
$67K
30
$63K
31
$63K
32
$59K
33
$54K
34
$52K
35
$43K
36
$39K
37
$38K
38
$34K
39
$31K
40
$30K
41
$30K
42
$29K
43
$28K
44
$24K
45
$23K
46
$21K
47
$21K
48
$20K
49
$20K
50
$19K
1
2
3 4